Latest Strategic Pivot News

Marmota Limited has completed an extensive 91-hole drilling campaign at its Muckanippie project, extending exploration westward based on promising visual heavy mineral feedback. Laboratory assays are expected within weeks, potentially confirming a significant titanium resource expansion.

Summit Minerals appoints Dr. Matthew Cobb as CEO to accelerate development of its Equador Niobium and Rare Earth Elements Project in Brazil, while reshuffling leadership to bolster operational focus.

Xstate Resources has divested its 25% stake in the Crest Jinn assets in Alberta, Canada, opting for a modest royalty interest as it refocuses amid geopolitical and operational uncertainties.

Agrimin Limited has initiated a strategic review of its Mackay Potash Project in response to challenging capital markets, scaling back operations and announcing key leadership changes.

Hotel Property Investments has announced significant leadership changes following increased shareholding by Charter Hall and Hostplus, signaling a strategic pivot for the property investment firm.

News Corporation reported a robust half-year performance with revenues up 4% to $4.33 billion and net income soaring 80% to $334 million, while advancing its strategic pivot through the planned sale of Foxtel.

Shekel Brainweigh Ltd has requested an immediate suspension from ASX quotation as it moves towards removal from the official ASX list, raising questions about the company’s future.

SOCO Corporation Ltd has posted a preliminary 18% increase in first-half FY2025 revenue to $11 million, yet project delays and reduced federal government demand temper full-year growth expectations.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

Loyal Lithium unveils a strategic pivot to broaden its North American lithium and battery technology portfolio, leveraging new US energy policies and $5.5 million in funding to capitalize on the continent’s evolving energy grid demands.

Lithium Energy Limited has obtained final Environmental Impact Assessment approvals for key Solaroz concessions, paving the way for the next phase of lithium exploration and evaluation in Argentina.